10-Q · May 14, 2026
Innovative Eyewear, Inc. reported a 70% increase in revenue for Q1 2026 to $773,561 compared to $454,501 in Q1 2025, driven primarily by strong demand for its Lucyd Armor smart safety glasses. Despite the revenue…
Earnings analysis · 10-Q
Filed August 14, 2026 · Our reading of the company's report
The latest report
The provided filing extract does not contain Q2 2026 income statement, balance sheet, cash flow, segment, or MD&A data, so current-period financial trends cannot be assessed. The principal disclosed issue is that…
The provided filing extract does not contain Q2 2026 income statement, balance sheet, cash flow, segment, or MD&A data, so current-period financial trends cannot be assessed. The principal disclosed issue is that disclosure controls were not effective as of June 30, 2026 due to material weaknesses in internal control over financial reporting. The filing states there were no material changes to risk factors from the 2025 Form 10-K and discloses 40,582 aggregate executive shares sold under Rule 10b5-1 plans during the quarter.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
The company reported no material pending legal proceedings, stating it is not currently subject to any such proceedings.
The filing states there was no change in internal control over financial reporting during Q2 2026 that materially affected, or was reasonably likely to materially affect, controls.
Five executives sold shares under Rule 10b5-1 plans during the quarter: the CEO sold 13,764 shares, the Chief AI and Growth Officer 6,692, the CTO 7,773, the CFO 7,574, and the COO 4,779.
The CEO and CFO concluded that disclosure controls and procedures were not effective as of June 30, 2026 as a result of material weaknesses in internal control over financial reporting.
The filing identifies material weaknesses in internal control over financial reporting as the reason controls were ineffective as of June 30, 2026, limiting confidence in the timeliness and reliability of reported information.
Executives sold an aggregate of 40,582 shares during Q2 2026 under Rule 10b5-1 plans, including 13,764 shares sold by the CEO and 7,574 by the CFO. The transactions were made pursuant to plans adopted on December 9, 2025.
The provided filing text does not include quantitative revenue or EPS guidance, and no MD&A outlook was provided.
Innovative Eyewear, Inc. reported a 70% increase in revenue for Q1 2026 to $773,561 compared to $454,501 in Q1 2025, driven primarily by strong demand for its Lucyd Armor smart safety glasses. Despite the revenue…
Innovative Eyewear, Inc. reported a revenue increase of 63% to $2.66 million for the year ending December 31, 2025, compared to $1.64 million in 2024. Despite significant sales growth, the company continues to operate…
Innovative Eyewear, Inc. experienced substantial revenue growth in Q3 2025, with revenues reaching $668.1 million, a 163% increase year-over-year, although it fell short of analyst expectations. Despite an EPS of -$0.38…
In Q2 2025, LUCY reported revenues of $579,230, representing an 88% year-over-year increase but falling short of analyst estimates of $1,000,000. The company's diluted EPS improved slightly to -0.66 from -0.72 in the…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.